Y-mAbs Therapeutics
YMAB
YMAB
80 hedge funds and large institutions have $523M invested in Y-mAbs Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 30 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
-1
Holders Change %
-1.23%
% of All Funds
1.77%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
9
Increased
31
Reduced
30
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
$3.77M |
| 2 |
Morgan Stanley
New York
|
$137K |
| 3 |
BBA
Baker Bros. Advisors
New York
|
$0 |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
$2.3M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$1.43M |
